Shiao-Ping Lu

623 total citations
10 papers, 427 citations indexed

About

Shiao-Ping Lu is a scholar working on Physiology, Pharmacology and Neurology. According to data from OpenAlex, Shiao-Ping Lu has authored 10 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 3 papers in Pharmacology and 2 papers in Neurology. Recurrent topics in Shiao-Ping Lu's work include Pain Mechanisms and Treatments (6 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Pain Management and Treatment (2 papers). Shiao-Ping Lu is often cited by papers focused on Pain Mechanisms and Treatments (6 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Pain Management and Treatment (2 papers). Shiao-Ping Lu collaborates with scholars based in United States, United Kingdom and Canada. Shiao-Ping Lu's co-authors include Jeffrey Tobias, Geertrui F. Vanhove, Gordon Irving, E. Richard Blonsky, Edwin Dunteman, Miroslav Bačkonja, Stephen Brown, Suzanne Gazda, David M. Simpson and Lynn R. Webster and has published in prestigious journals such as Clinical Cancer Research, American Heart Journal and Journal of Pain and Symptom Management.

In The Last Decade

Shiao-Ping Lu

9 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiao-Ping Lu United States 6 197 109 78 78 54 10 427
T. Viganò Italy 15 320 1.6× 55 0.5× 137 1.8× 118 1.5× 37 0.7× 41 626
Jie Han China 12 81 0.4× 40 0.4× 156 2.0× 14 0.2× 52 1.0× 29 434
Hiroo Itoh Japan 10 78 0.4× 23 0.2× 179 2.3× 108 1.4× 12 0.2× 14 492
Jim Growcott United Kingdom 9 122 0.6× 21 0.2× 129 1.7× 41 0.5× 143 2.6× 12 462
K. Žarković Croatia 12 43 0.2× 59 0.5× 78 1.0× 23 0.3× 35 0.6× 18 415
Lumei Kang China 9 183 0.9× 25 0.2× 154 2.0× 44 0.6× 125 2.3× 17 446
Xianhua Hou China 13 29 0.1× 51 0.5× 118 1.5× 19 0.2× 34 0.6× 18 396
Bo Youn Choi South Korea 9 74 0.4× 11 0.1× 260 3.3× 29 0.4× 36 0.7× 15 436
Laura Bonaccini Italy 9 123 0.6× 17 0.2× 137 1.8× 33 0.4× 96 1.8× 15 407

Countries citing papers authored by Shiao-Ping Lu

Since Specialization
Citations

This map shows the geographic impact of Shiao-Ping Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiao-Ping Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiao-Ping Lu more than expected).

Fields of papers citing papers by Shiao-Ping Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiao-Ping Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiao-Ping Lu. The network helps show where Shiao-Ping Lu may publish in the future.

Co-authorship network of co-authors of Shiao-Ping Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shiao-Ping Lu. A scholar is included among the top collaborators of Shiao-Ping Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiao-Ping Lu. Shiao-Ping Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
3.
Paul, Robert, Michael E. Ward, Omer Siddiqui, et al.. (2019). P4‐664: A PHASE 1 STUDY OF AL001 IN HEALTHY VOLUNTEERS AND FRONTOTEMPORAL DEMENTIA PATIENTS CARRYING A GRANULIN MUTATION. Alzheimer s & Dementia. 15(7S_Part_30).
4.
Walicke, Patricia A., Franz Hefti, Shiao-Ping Lu, et al.. (2018). First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain. PAIN Reports. 3(3). e653–e653. 11 indexed citations
5.
Gibson, C. Michael, Rim Halaby, Serge Korjian, et al.. (2016). The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. American Heart Journal. 185. 93–100. 39 indexed citations
6.
Nathan, Paul, Martin Zweifel, Anwar R. Padhani, et al.. (2012). Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer. Clinical Cancer Research. 18(12). 3428–3439. 153 indexed citations
7.
Irving, Gordon, Miroslav Bačkonja, Edwin Dunteman, et al.. (2010). A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia. Pain Medicine. 12(1). 99–109. 129 indexed citations
8.
Simpson, David M., Suzanne Gazda, Stephen Brown, et al.. (2010). Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic Pain. Journal of Pain and Symptom Management. 39(6). 1053–1064. 79 indexed citations
9.
10.
Blonsky, E. Richard, Jeffrey Tobias, Mark S. Wallace, et al.. (2009). Integrated analysis of efficacy and safety of NGX-4010, a high-concentration capsaicin patch, in patients with postherpetic neuralgia. Journal of Pain. 10(4). S42–S42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026